Related Experiment Video

Updated: Jun 16, 2026

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
09:36

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device

Published on: September 24, 2020

Severe central nervous and respiratory system depression after sedation with chloral hydrate: a case report

Emre Ceçen1, Ozgün Uygur, Ayşe Tosun

  • 1Department of Pediatrics, Adnan Menderes University Faculty of Medicine, Aydin, Turkey.

The Turkish Journal of Pediatrics
|February 2, 2010
PubMed

Insights

Chloral hydrate, a common sedative for children, can cause severe breathing problems even at recommended doses. A four-month-old infant experienced life-threatening respiratory depression after receiving a therapeutic dose, highlighting potential risks.

Area of Science:

  • Pediatric Pharmacology
  • Clinical Toxicology
  • Anesthesiology

Background:

  • Chloral hydrate is widely used for procedural sedation in pediatric patients.
  • It is generally regarded as safe when administered within recommended dosage limits.
  • Potential adverse events, though rare, warrant careful consideration.

Observation:

  • A case report details a four-month-old infant who received a therapeutic dose of chloral hydrate.
  • The infant developed severe central nervous system and respiratory depression post-administration.
  • This occurred despite the dose being within recommended maximal limits.

Findings:

  • Therapeutic doses of chloral hydrate can precipitate life-threatening adverse events in infants.
  • Central nervous system and respiratory depression are significant risks.
  • Supportive care, including mechanical ventilation, can facilitate recovery.

Implications:

  • Clinicians should exercise caution when prescribing chloral hydrate to infants, even at standard doses.
  • Enhanced monitoring for respiratory and neurological status is crucial post-administration.
  • This case underscores the need for vigilance regarding chloral hydrate's safety profile in vulnerable pediatric populations.

Related Concept Videos

CNS Depressants: Barbiturates and Benzodiazepines01:14

CNS Depressants: Barbiturates and Benzodiazepines

CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
Depressants01:28

Depressants

Depressant drugs, including alcohol and sedative-hypnotics, diminish central nervous system activity by enhancing the action of gamma-aminobutyric acid (GABA), a neurotransmitter that reduces brain activity and promotes relaxation. These substances can have various therapeutic uses but also pose significant risks, especially when misused or combined.
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Stages of General Anesthesia01:22

Stages of General Anesthesia

Various sedation levels offer significant advantages in facilitating procedural interventions for patients undergoing medical or invasive surgical procedures. These levels span from anxiolysis to general anesthesia, providing a spectrum of sedative effects to cater to specific patient needs. Anxiolysis reduces anxiety and is achieved through minimal sedation, enabling patients to remain awake and responsive while feeling more at ease during the procedure. This level can benefit minor...
Sedatives and Hypnotics: Overview01:23

Sedatives and Hypnotics: Overview

Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedatives and Hypnotics Drugs: Barbiturates01:20

Sedatives and Hypnotics Drugs: Barbiturates

Sedatives and hypnotics encompass a drug class that acts on the central nervous system (CNS) to alleviate anxiety, promote relaxation and induce sleep.These drugs function by amplifying the actions of the neurotransmitter γ-aminobutyric acid (GABA), resulting in reduced neuronal activity. Barbiturates, a subset of sedatives and hypnotics first synthesized in the late 1800s, are categorized into ultra-short, short, intermediate, and long-acting groups based on their duration of effect. A key...